Bioqual Inc. (OTCMKTS:BIOQ – Get Free Report) shares traded down 3.2% during mid-day trading on Wednesday. The stock traded as low as $30.00 and last traded at $30.00. Approximately 100 shares were traded during trading, an increase of 99% from the average session volume of 50 shares. The stock had previously closed at $31.00.
Bioqual Stock Down 3.2%
The firm’s 50-day moving average price is $32.10 and its 200 day moving average price is $34.23. The firm has a market cap of $26.70 million, a P/E ratio of -6.47 and a beta of -0.12.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last released its quarterly earnings data on Thursday, October 22nd. The company reported ($0.56) earnings per share for the quarter. The firm had revenue of $10.15 million during the quarter. Bioqual had a negative return on equity of 12.04% and a negative net margin of 10.29%.
Bioqual Company Profile
Bioqual, Inc. is a contract research organization that conducts preclinical biomedical research for pharmaceutical and biotechnology companies, government agencies, and academic institutions. Its services support the development and evaluation of vaccines, therapeutics, and other medical products. The company’s research includes infectious-disease studies and the use of animal models to assess potential treatments and vaccines. Bioqual is based in Rockville, Maryland, and has operated in the biomedical research field since 1981.
Further Reading
- Five stocks we like better than Bioqual
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
